European Commission Calls
Global Challenges and European Industrial Competitiveness
HEALTH Call Identifier: HORIZON-HLTH-2024-DISEASE-13-01 Implementation research for management of multiple long-term conditions in the context of non-communicable diseases (Global Alliance for Chronic Diseases - GACD)
The European Commission is a member of the Global Alliance for Chronic Diseases (GACD), an alliance of international funding agencies representing over 80% of the world’s public health research funding and the first collaboration of its kind to specifically address non-communicable diseases (NCDs).
Proposals should address all of the following activities:
•Provide a research plan using validated implementation research frameworks or hybrid design research.
•Have an appropriate strategy for measuring implementation research outcomes and real-world effectiveness outcomes and indicators.
•Specifically address health equity and the principles of Universal Health Coverage.
•Engage an appropriately expert and skilled research team which can ensure a suitable multidisciplinary approach and that demonstrates equitable partnership and shared leadership between high-income countries (HICs)- low- and middle-income countries (LMICs), and/or non-Indigenous–Indigenous members of the project team and external stakeholders through a clear governance strategy.
•Provide a stakeholder engagement strategy with evidence of support/engagement from key stakeholders for delivering patient-centred care and a pathway to sustain the proposed intervention after the funding ends.
•Provide opportunities for implementation research capacity building for early career researchers and team members from lower resourced environments, such as LMICs or disadvantaged communities.
•Ensure meaningful involvement of early career team members, including at least one early career member as a co-investigator.
Budget: 3.000.000 to 4.000.000 EUR, indicative number of grants: 5
Deadline: 26 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
HEALTH Call Identifier: HORIZON-HLTH-2024-CARE-14-01 Pre-commercial procurement for environmentally sustainable, climate neutral and circular health and care systems
The healthcare sector is responsible for 4-5% of global total carbon emissions contributing significantly to Europe's carbon footprint and to the generation of large amounts of plastics and other waste, including chemical waste through the discharge of pharmaceuticals and diagnostic chemicals as well as disinfectants and antimicrobial resistant pathogens into the wastewater system.
Proposals should target either:
•Direct and indirect footprint deriving from the provision and/or delivery of care (excluding infrastructural elements related to building, transport logistics and food footprints).
•Circularity, waste production and treatment.
•Footprint from the chain of suppliers in making and delivering products, or services.
•More efficient use of resources, decreasing the overall sector footprint while addressing the constantly increasing demand for healthcare.
Budget: 3.000.000 to 5.000.000 EUR, indicative number of grants: 3
Deadline: 26 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
HEALTH
Call Identifier: HORIZON-HLTH-2024-DISEASE-12-01
European partnership for pandemic preparedness
The COVID-19 pandemic uncovered the challenges that European health care systems face in detecting, preventing, combatting and managing outbreaks of infectious diseases in a coordinated manner.
The scope of the partnership should encompass:
•basic research to accelerate the acquisition of knowledge on the biology of pathogens with epidemic or pandemic potential, their transmission and interaction with humans, animals and plants, in particular in view of emerging threats to human health.
•preclinical research aimed at better understanding of human diseases caused by pathogens with epidemic or pandemic potential and testing of related medical countermeasures.
•clinical research to support the generation of novel solutions, in particular the development (phase I to phase III) of medical countermeasures, e.g. vaccines, diagnostics, therapeutics and digital solutions, to prevent or mitigate outbreaks from pathogens with epidemic or pandemic potential.
•a key feature should be the consolidation and further development of an ever-warm network of clinical trial sites applying the same quality standards and ensuring a baseline of continuous clinical trial activity across a wide and diverse range of clinical trial site.
•the development, testing and validation of new methods and tools, including those based on artificial intelligence and computer modelling, to improve surveillance and diagnosis and control of the spread of pathogens with epidemic or pandemic potential.
Budget: 50.000.000 EUR, indicative number of grants: 1
Deadline: 26 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
The COVID-19 pandemic uncovered the challenges that European health care systems face in detecting, preventing, combatting and managing outbreaks of infectious diseases in a coordinated manner.
The scope of the partnership should encompass:
•basic research to accelerate the acquisition of knowledge on the biology of pathogens with epidemic or pandemic potential, their transmission and interaction with humans, animals and plants, in particular in view of emerging threats to human health.
•preclinical research aimed at better understanding of human diseases caused by pathogens with epidemic or pandemic potential and testing of related medical countermeasures.
•clinical research to support the generation of novel solutions, in particular the development (phase I to phase III) of medical countermeasures, e.g. vaccines, diagnostics, therapeutics and digital solutions, to prevent or mitigate outbreaks from pathogens with epidemic or pandemic potential.
•a key feature should be the consolidation and further development of an ever-warm network of clinical trial sites applying the same quality standards and ensuring a baseline of continuous clinical trial activity across a wide and diverse range of clinical trial site.
•the development, testing and validation of new methods and tools, including those based on artificial intelligence and computer modelling, to improve surveillance and diagnosis and control of the spread of pathogens with epidemic or pandemic potential.
Budget: 50.000.000 EUR, indicative number of grants: 1
Deadline: 26 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
HEALTH Call Identifier: HORIZON-HLTH-2024-DISEASE-13-01 Implementation research for management of multiple long-term conditions in the context of non-communicable diseases (Global Alliance for Chronic Diseases - GACD)
The European Commission is a member of the Global Alliance for Chronic Diseases (GACD), an alliance of international funding agencies representing over 80% of the world’s public health research funding and the first collaboration of its kind to specifically address non-communicable diseases (NCDs).
Proposals should address all of the following activities:
•Provide a research plan using validated implementation research frameworks or hybrid design research.
•Have an appropriate strategy for measuring implementation research outcomes and real-world effectiveness outcomes and indicators.
•Specifically address health equity and the principles of Universal Health Coverage.
•Engage an appropriately expert and skilled research team which can ensure a suitable multidisciplinary approach and that demonstrates equitable partnership and shared leadership between high-income countries (HICs)- low- and middle-income countries (LMICs), and/or non-Indigenous–Indigenous members of the project team and external stakeholders through a clear governance strategy.
•Provide a stakeholder engagement strategy with evidence of support/engagement from key stakeholders for delivering patient-centred care and a pathway to sustain the proposed intervention after the funding ends.
•Provide opportunities for implementation research capacity building for early career researchers and team members from lower resourced environments, such as LMICs or disadvantaged communities.
•Ensure meaningful involvement of early career team members, including at least one early career member as a co-investigator.
Budget: 3.000.000 to 4.000.000 EUR, indicative number of grants: 5
Deadline: 26 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
HEALTH Call Identifier: HORIZON-HLTH-2024-CARE-14-01 Pre-commercial procurement for environmentally sustainable, climate neutral and circular health and care systems
The healthcare sector is responsible for 4-5% of global total carbon emissions contributing significantly to Europe's carbon footprint and to the generation of large amounts of plastics and other waste, including chemical waste through the discharge of pharmaceuticals and diagnostic chemicals as well as disinfectants and antimicrobial resistant pathogens into the wastewater system.
Proposals should target either:
•Direct and indirect footprint deriving from the provision and/or delivery of care (excluding infrastructural elements related to building, transport logistics and food footprints).
•Circularity, waste production and treatment.
•Footprint from the chain of suppliers in making and delivering products, or services.
•More efficient use of resources, decreasing the overall sector footprint while addressing the constantly increasing demand for healthcare.
Budget: 3.000.000 to 5.000.000 EUR, indicative number of grants: 3
Deadline: 26 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
MSCA
Call Identifier: HORIZON-MSCA-2024-SE-01-01 MSCA Staff Exchanges 2024 (HORIZON-MSCA-2024-SE-01-01)
MSCA Staff Exchanges involve organisations from the academic and non-academic sectors (including SMEs) from across the globe.
•Support is provided for international, inter-sectoral and interdisciplinary mobility of R&I staff leading to knowledge transfer between participating organisations.
•The organisations constituting the partnership contribute directly to the implementation of a joint R&I project by seconding and/or hosting eligible staff members.
•Such a project must explore activities that can be based on previous work but should go beyond and generate or strengthen long-term collaborations. Secondments must involve physical mobility of the eligible staff members and must always take place between legal entities independent from each other.
MSCA Staff Exchanges can address three dimensions of mobility: international, inter-sectoral and interdisciplinary.
Budget: EUR 81.226.000 (for year 2024)
Deadline: 05 March 2025 (Opening date: 10 October 2024)
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Call Identifier: HORIZON-MSCA-2025-COFUND-01-01 MSCA COFUND 2025 HORIZON-MSCA-2025-COFUND-01-01
Scope: Applicants submit proposals for new or existing doctoral or postdoctoral programmes with an impact on the enhancement of human resources in R&I at regional, national or international level. These programmes will be co-funded by MSCA COFUND.
Proposed programmes can cover any research disciplines ("bottom-up"), but exceptionally can also focus on specific disciplines, notably when they are based on national or regional Research and Innovation Strategies for Smart Specialisation (RIS3 strategies). In this case, the range of covered disciplines should allow reasonable flexibility for the researchers to define their topic.
A Career Development Plan must be jointly established by the supervisor and each recruited researcher upon recruitment. In addition to research objectives, this Plan comprises the researcher's training and career needs, including training on transferable skills, teaching, planning for publications and participation in conferences and events aimed at opening science and research to citizens. The Plan must be established at the beginning of the recruitment and should be revised (and updated where needed) within 18 months.
A) Doctoral programmes
Doctoral programmes offer research training activities to allow doctoral candidates to develop and broaden their skills and competences. The training activities should be based on the EU Principles on Innovative Doctoral Training.
Substantial training modules, including digital ones, addressing key transferable skills and competences common to all fields, fostering good scientific conduct such as research integrity, and fostering the culture of Open Science, innovation and entrepreneurship will be supported.
Applicants are encouraged to include elements of cross-sectoral mobility and interdisciplinarity into their programmes. Collaboration with a wider set of associated partners, including from the non-academic sector, will be positively taken into account during the evaluation. These organisations may provide hosting or secondment opportunities or training modules in research or transferable skills.
Particular attention is paid to the quality of supervision and mentoring arrangements as well as career guidance.
B) Postdoctoral Programmes
Postdoctoral Programmes fund individual advanced research training and career development fellowships for postdoctoral researchers. The programmes should offer training to develop key transferable skills and competences common to all fields, foster good scientific conduct such as research integrity, foster innovation and entrepreneurship and promote and (where appropriate) reward Open Science practices (open access to publications and to other research outputs including data, FAIR data management, societal engagement and citizen science, etc.).
Postdoctoral Programmes should have regular selection rounds following fixed deadlines or regular cut-off dates, allowing fair competition between researchers.
Applicants are encouraged to include elements of cross-sectoral mobility and interdisciplinarity into their programmes. Researchers will be able to freely choose a research topic and the appropriate organisation to host them, fitting their individual needs.
Budget: 101.820.280 EUR (Postdoctoral programme);
101.820.280 EUR (Doctoral programme)
Deadline: 24 June 2025
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Doctoral Network
Call Identifier: HORIZON-MSCA-2024-DN-01-01
MSCA Doctoral Networks 2023 (HORIZON-MSCA-2024-DN-01-01)
MSCA Doctoral Networks will implement doctoral programmes, by partnerships of universities, research institutions and research infrastructures, businesses including SMEs, and other socio-economic actors from different countries across Europe and beyond.
Proposals for doctoral networks can reflect existing or planned research partnerships among the participating organisations.
The selection procedure for doctoral candidates must be open, transparent and merit-based, in line with the Code of Conduct for the Recruitment of Researchers.
MSCA Doctoral Networks are encouraged to lead to Industrial or Joint Doctorates.
Industrial Doctorates: Through Industrial Doctorates, doctoral candidates will step outside academia and develop skills in industry and business by being jointly supervised by academic and non-academic organisations, both of which can be established in the same EU Member State or Horizon Europe Associated Country.
Joint Doctorates: Joint Doctorates represent a highly integrated type of international, inter-sectoral and multi/interdisciplinary collaboration in doctoral training. They lead to the delivery of joint, double or multiple doctoral degrees recognised in at least two EU Member States or Horizon Europe Associated Countries.
Budget: EUR 608.000.000 (MSCA-DN) (single stage), 540 PM (in 2022 360 PM)
Deadline: 27 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
MSCA Doctoral Networks will implement doctoral programmes, by partnerships of universities, research institutions and research infrastructures, businesses including SMEs, and other socio-economic actors from different countries across Europe and beyond.
Proposals for doctoral networks can reflect existing or planned research partnerships among the participating organisations.
The selection procedure for doctoral candidates must be open, transparent and merit-based, in line with the Code of Conduct for the Recruitment of Researchers.
MSCA Doctoral Networks are encouraged to lead to Industrial or Joint Doctorates.
Industrial Doctorates: Through Industrial Doctorates, doctoral candidates will step outside academia and develop skills in industry and business by being jointly supervised by academic and non-academic organisations, both of which can be established in the same EU Member State or Horizon Europe Associated Country.
Joint Doctorates: Joint Doctorates represent a highly integrated type of international, inter-sectoral and multi/interdisciplinary collaboration in doctoral training. They lead to the delivery of joint, double or multiple doctoral degrees recognised in at least two EU Member States or Horizon Europe Associated Countries.
Budget: EUR 608.000.000 (MSCA-DN) (single stage), 540 PM (in 2022 360 PM)
Deadline: 27 November 2024
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Call Identifier: HORIZON-MSCA-2024-SE-01-01 MSCA Staff Exchanges 2024 (HORIZON-MSCA-2024-SE-01-01)
MSCA Staff Exchanges involve organisations from the academic and non-academic sectors (including SMEs) from across the globe.
•Support is provided for international, inter-sectoral and interdisciplinary mobility of R&I staff leading to knowledge transfer between participating organisations.
•The organisations constituting the partnership contribute directly to the implementation of a joint R&I project by seconding and/or hosting eligible staff members.
•Such a project must explore activities that can be based on previous work but should go beyond and generate or strengthen long-term collaborations. Secondments must involve physical mobility of the eligible staff members and must always take place between legal entities independent from each other.
MSCA Staff Exchanges can address three dimensions of mobility: international, inter-sectoral and interdisciplinary.
Budget: EUR 81.226.000 (for year 2024)
Deadline: 05 March 2025 (Opening date: 10 October 2024)
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Call Identifier: HORIZON-MSCA-2025-COFUND-01-01 MSCA COFUND 2025 HORIZON-MSCA-2025-COFUND-01-01
Scope: Applicants submit proposals for new or existing doctoral or postdoctoral programmes with an impact on the enhancement of human resources in R&I at regional, national or international level. These programmes will be co-funded by MSCA COFUND.
Proposed programmes can cover any research disciplines ("bottom-up"), but exceptionally can also focus on specific disciplines, notably when they are based on national or regional Research and Innovation Strategies for Smart Specialisation (RIS3 strategies). In this case, the range of covered disciplines should allow reasonable flexibility for the researchers to define their topic.
A Career Development Plan must be jointly established by the supervisor and each recruited researcher upon recruitment. In addition to research objectives, this Plan comprises the researcher's training and career needs, including training on transferable skills, teaching, planning for publications and participation in conferences and events aimed at opening science and research to citizens. The Plan must be established at the beginning of the recruitment and should be revised (and updated where needed) within 18 months.
A) Doctoral programmes
Doctoral programmes offer research training activities to allow doctoral candidates to develop and broaden their skills and competences. The training activities should be based on the EU Principles on Innovative Doctoral Training.
Substantial training modules, including digital ones, addressing key transferable skills and competences common to all fields, fostering good scientific conduct such as research integrity, and fostering the culture of Open Science, innovation and entrepreneurship will be supported.
Applicants are encouraged to include elements of cross-sectoral mobility and interdisciplinarity into their programmes. Collaboration with a wider set of associated partners, including from the non-academic sector, will be positively taken into account during the evaluation. These organisations may provide hosting or secondment opportunities or training modules in research or transferable skills.
Particular attention is paid to the quality of supervision and mentoring arrangements as well as career guidance.
B) Postdoctoral Programmes
Postdoctoral Programmes fund individual advanced research training and career development fellowships for postdoctoral researchers. The programmes should offer training to develop key transferable skills and competences common to all fields, foster good scientific conduct such as research integrity, foster innovation and entrepreneurship and promote and (where appropriate) reward Open Science practices (open access to publications and to other research outputs including data, FAIR data management, societal engagement and citizen science, etc.).
Postdoctoral Programmes should have regular selection rounds following fixed deadlines or regular cut-off dates, allowing fair competition between researchers.
Applicants are encouraged to include elements of cross-sectoral mobility and interdisciplinarity into their programmes. Researchers will be able to freely choose a research topic and the appropriate organisation to host them, fitting their individual needs.
Budget: 101.820.280 EUR (Postdoctoral programme);
101.820.280 EUR (Doctoral programme)
Deadline: 24 June 2025
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Innovative Europe
European Innovation Council (EIC) Call Identifier: EIC Accelerator Challanges EIC Accelerator Challanges 2024
The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs that:
•have a innovative, game changing product, service or business model that could create new markets or disrupt existing ones in Europe and even worldwide.
•have the ambition and commitment to scale up.
•are looking for substantial funding, but the risks involved are too high for private investors alone to invest.
The specific objectives of this Challenge are:
•Human Centric Generative AI
•Virtual worlds and augmented interaction, including support to Industry 5.0
•Enabling the smart edge & quantum technology components
•Food from precision fermentation and algae
•Monoclonal antibody-based therapeutics for emerging viruses
•Renewable energy sources and their whole value chain
Budget: Grant component below EUR 2.5M for innovation activities (starting at TRL 5 or 6 aiming at achieving higher TRLs). Investment component of EUR 0.5 up to 15 million for scaling up and other activities.
Grant only and investment only component under certain conditions. Total indicative budget topic: 300 EUR million.
Deadline: 4 October 2024 (full application); any time (short application)
Who can apply: Single start-ups and SMEs (including spin-offs), individuals (intending to launch a start-up/ SME) and in exceptional cases small mid-caps (fewer than 499 employees).
European Innovation Council (EIC)
Call Identifier: HORIZON-EIC-2024-ACCELERATOR-01)
EIC Accelerator 2024
The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs that:
•have a innovative, game changing product, service or business model that could create new markets or disrupt existing ones in Europe and even worldwide.
•have the ambition and commitment to scale up.
•are looking for substantial funding, but the risks involved are too high for private investors alone to invest.
Budget: Grant component below EUR 2.5M for innovation activities (starting at TRL 5 or 6 aiming at achieving higher TRLs). Investment component of EUR 0.5 up to 15 million for scaling up and other activities.
Grant only and investment only component under certain conditions. Total indicative budget topic: 375 EUR million.
Deadline: 3 October 2024 (full application); any time (short application)
Who can apply: To be an eligible applicant to EIC Accelerator, you must apply as one of the following eligible entities:
• A single company classified as a SME, and established within a Member State or an Associated Country (see Annex 2 of the EIC Work Programme 2024); or
• A single company classified as a small mid-cap (up to 499 employees) established in a Member State or an Associated Country, but only for exceptional cases for rapid scale up purposes; or
• One or more natural persons (including individual entrepreneurs) or legal entities, which are either:
a. from a Member State or an Associated Country intending to establish an SME or small mid-cap (as defined above) in a Member State or Associated Country by the time of signing the EIC Accelerator grant agreement or, in case the equity only is awarded, at the latest at the date of signature of the agreement on its investment component;
b. intending to invest in an SME or small mid-cap established in a Member State or an Associated Country and may submit a proposal on behalf of that SME or small mid-cap, provided that a prior agreement exists with the company. The grant agreement and/or the investment agreement will be signed with the beneficiary/final recipient of funding company only; or
c. from a non-associated third country intending to establish an SME (including start-ups) or to relocate an existing SME to a Member State or an Associated Country. Your company must prove its effective establishment in a Member State or an Associated Country at the time of submission of the full proposal.
The standard admissibility and eligibility conditions are detailed in Annex 2 of the EIC Work Programme 2024.
The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs that:
•have a innovative, game changing product, service or business model that could create new markets or disrupt existing ones in Europe and even worldwide.
•have the ambition and commitment to scale up.
•are looking for substantial funding, but the risks involved are too high for private investors alone to invest.
Budget: Grant component below EUR 2.5M for innovation activities (starting at TRL 5 or 6 aiming at achieving higher TRLs). Investment component of EUR 0.5 up to 15 million for scaling up and other activities.
Grant only and investment only component under certain conditions. Total indicative budget topic: 375 EUR million.
Deadline: 3 October 2024 (full application); any time (short application)
Who can apply: To be an eligible applicant to EIC Accelerator, you must apply as one of the following eligible entities:
• A single company classified as a SME, and established within a Member State or an Associated Country (see Annex 2 of the EIC Work Programme 2024); or
• A single company classified as a small mid-cap (up to 499 employees) established in a Member State or an Associated Country, but only for exceptional cases for rapid scale up purposes; or
• One or more natural persons (including individual entrepreneurs) or legal entities, which are either:
a. from a Member State or an Associated Country intending to establish an SME or small mid-cap (as defined above) in a Member State or Associated Country by the time of signing the EIC Accelerator grant agreement or, in case the equity only is awarded, at the latest at the date of signature of the agreement on its investment component;
b. intending to invest in an SME or small mid-cap established in a Member State or an Associated Country and may submit a proposal on behalf of that SME or small mid-cap, provided that a prior agreement exists with the company. The grant agreement and/or the investment agreement will be signed with the beneficiary/final recipient of funding company only; or
c. from a non-associated third country intending to establish an SME (including start-ups) or to relocate an existing SME to a Member State or an Associated Country. Your company must prove its effective establishment in a Member State or an Associated Country at the time of submission of the full proposal.
The standard admissibility and eligibility conditions are detailed in Annex 2 of the EIC Work Programme 2024.
European Innovation Council (EIC) Call Identifier: EIC Accelerator Challanges EIC Accelerator Challanges 2024
The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs that:
•have a innovative, game changing product, service or business model that could create new markets or disrupt existing ones in Europe and even worldwide.
•have the ambition and commitment to scale up.
•are looking for substantial funding, but the risks involved are too high for private investors alone to invest.
The specific objectives of this Challenge are:
•Human Centric Generative AI
•Virtual worlds and augmented interaction, including support to Industry 5.0
•Enabling the smart edge & quantum technology components
•Food from precision fermentation and algae
•Monoclonal antibody-based therapeutics for emerging viruses
•Renewable energy sources and their whole value chain
Budget: Grant component below EUR 2.5M for innovation activities (starting at TRL 5 or 6 aiming at achieving higher TRLs). Investment component of EUR 0.5 up to 15 million for scaling up and other activities.
Grant only and investment only component under certain conditions. Total indicative budget topic: 300 EUR million.
Deadline: 4 October 2024 (full application); any time (short application)
Who can apply: Single start-ups and SMEs (including spin-offs), individuals (intending to launch a start-up/ SME) and in exceptional cases small mid-caps (fewer than 499 employees).
EU4Health
Call Identifier: EU4H-2024-PJ-03-2– a/b/c (DP/CR-g-24-29) Call for proposals on health promotion and prevention of noncommunicable and communicable diseases, including vaccine-preventable and other cancers caused by infections, and on smoke-and aerosol-free environments
Scope: The activities could cover the following areas of action:
a) promotion of good mental health and prevention of mental health problems through mental health literacy and awareness-raising, knowledge-sharing and exchange programmes for health professionals, creation of and participation in networks of institutions, patients and health professionals, identification and sharing of best and promising practices and approaches and implementable research results;
b) support for the design of integrated and coherent health policy approaches to key mental health challenges for children, such as those posed by the digital world (e.g., misinformation, cyberbullying, body shaming, aggressive marketing, undue access to inappropriate content, addiction and concentration deficit);
c) support for the design of comprehensive and coherent policy approaches and toolkits to address key social, environmental, commercial and behavioural factors influencing the mental health of citizens, including children and young people and their mental resilience;
d) better and earlier detection and intervention of mental health problems through development, piloting and implementation of approaches and tools for early detection and intervention in various settings e.g., schools, workplaces, prisons and community settings;
e) improved access to evidence-based, innovative, promising and community-level approaches and interventions in the management of mental health challenges;
f) improved quality of life through appropriate and patient-centred follow-up care with a focus on rights and breaking through stigma and discrimination.
Budget: Topic budget EU4H-2024-PJ-03-2 – a: 750.000 EUR; EU4H-2024-PJ-03-2 – b: 833.333 EUR; EU4H-2024-PJ-03-2 – c: 500.000 EUR.
Expected nr of grant agreements to be signed: EU4H-2024-PJ-03-2 – a: 2; EU4H-2024-PJ-03-2 – b: 3; EU4H-2024-PJ-03-2 – c: 2.
Expected duration: 36 months
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.
Call Identifier: EU4H-2024-PJ-03-3 (CR-g-24-42) Call for Proposals on radiation safety and quality of computed tomography imaging of children and young adults - (CR-g-24-42) EU4H-2024-PJ-03-3
Scope: The activities carried out in this action should include the following:
a) review of referral guidelines for imaging, clinical guidelines, and clinical decision support systems in use in Member States for justification of radiological imaging in children, adolescents and young adults and recommendations for improvement of these guidelines to the relevant actors;
b) review of the equipment base and the access to dedicated paediatric imaging in Member States and recommendations for improvement of the equipment base to the relevant actors;
c) development of guidance, protocols and tools for optimisation of paediatric CT exams, for the CT devices and the clinical indications that are the most used in Europe;
d) the organisation of information and dissemination campaigns concerning recommendations, guidance, protocols and tools for justification and optimisation of paediatric imaging among the concerned hospitals and medical centres in all Member States;
e) development of education and training curricula, material, and tools on radiation protection of paediatric patients, for the applicable professional groups;
f) the organisation of a training of radiologists, radiographers, medical physicists, and radiology nurses in practical approaches to radiation protection of paediatric patients;
g) the organisation of information campaigns about the benefits, risks and radiation safety of imaging in paediatric, adolescent and young adult patients, targeted at parents and young adults.
Budget: Topic budget: 3.000.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 48 months
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: Academia and education establishments, research institutes, hospitals, expert networks, civil society organisations, associations, foundations, NGOs, enterprises (incl. social enterprises and not for profit) in the field of public health, private entities (for profit/not for profit), international organisations, Member States’ authorities.
Call Identifier: EU4H-2024-PJ-03-4 (CR-g-24-99) Call for proposals on Personalised Cancer Medicine - (CR-g-24-99) EU4H-2024-PJ-03-4
Scope: Activities will contribute to the Joint Action on Personalized Cancer Medicine’, and include:
a) the implementation of targeted projects involving civil society organisations and industry complementing the Member States’ efforts in the design, planning and implementation of best practices (e.g., on metastatic cancer);
b) the production of public health guidelines concerning personalised cancer medicine, genomic testing/screening and metastatic cancer management;
c) patients and caregivers consultations, and other actions that can benefit citizens directly;
d) preparation and roll out of innovative practices;
e) support capacity building actions such as training and twinning, health communication or health literacy.
Budget: Topic budget: 3.000.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 36 and 48 months
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.
Call Identifier: EU4H-2024-PJ-03-5 (CR-g-24-96) Call for proposals to support the establishment of new networks of expertise on cancer and cancer conditions - (CR-g-24-96) EU4H-2024-PJ-03-5
Scope: Activities will complement the joint action on new networks of expertise to be launched under the EU4Health work programme 2023 (CR-g-23-40.1-2), and include:
a) implementing targeted projects involving patient organisations, civil societies, non-government organisations complementing the Member States’ efforts in the design, planning and implementation of the networks;
b) the establishment of best practices, the production of public health, treatment guidelines, or other actions that can benefit patients;
c) the preparation and roll out of innovative practices (pilot tests), and support actions such as training and twinning, health communication or health literacy.
Support activities could include:
a) practical support (to help patients better understand the impact of cancer and treatment; managing the side effects of cancer and cancer treatment);
b) emotional support (regular consultations in support groups and workshops, aimed at supporting and helping patients to manage the difficult psychological and emotional impact of cancer);
c) education and information (practical information on diet in cancer, oncology workshops for healthcare professionals and support personnel, tailored to specific types of cancer and their symptoms).
Budget: Topic budget: 1.000.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 36 months
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.
Call Identifier: EU4H-2024-PJ-03-6 (DI-g-24-76) Call for proposals on advancing the adoption of artificial intelligence in health (DI-g-24-76) EU4H-2024-PJ-03-6
Scope: The activities for this action should include the following actions:
a) the setting up and running of one or more communities of experts and relevant stakeholders for delving into the potentials and challenges concerning AI deployment in clinical practice. In this respect, this should provide proposals on how to ensure sustainability of this expert community beyond the end of the project;
b) the analysis and identification of the factors that lead to the successful and less successful deployment of AI in healthcare as well as challenges and obstacles, in collaboration with the expert community or communities mentioned under point a) and taking into account existing studies and projects. Two particular areas of interest that should be included are AI in cancer and AI in remote areas and medical deserts;
c) the preparation of good deployment practices for AI in healthcare, recommendations and guidelines tailored to the needs of the specific users/environments in healthcare to accelerate the safe and effective deployment of AI in clinical practice in collaboration with the expert community or communities mentioned under point a) and taking into account existing studies and projects.
d) the design, development, and execution of pilots to test and evaluate in diverse real-life environments the expert community(ies)’s developed good deployment practices, guidelines and recommendations. As part of the pilots, to analyse how clinical practice is changing with the incorporation of AI systems.
e) the development of user friendly interactive digital tool(s) that allows for the collection and communication of AI solutions successfully deployed in different clinical settings.
f) the organisation of workshops and communication activities addressed to different stakeholders.
g) the provision of a summary of lessons learned and recommendations for potential policy measures that would contribute to accelerating the safe and effective deployment of AI in clinical practice.
Budget: Topic budget: 4.500.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 36 and 48 months
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.
Call Identifier: EU4H-2024-PJ-03-1 (DP-g-24- 25)
Call for proposals to support a comprehensive, prevention-oriented approach to mental health in the Union - (DP-g-24-25) EU4H-2024-PJ-03-1
Scope: The activities could cover the following areas of action:
a) promotion of good mental health and prevention of mental health problems through mental health literacy and awareness-raising, knowledge-sharing and exchange programmes for health professionals, creation of and participation in networks of institutions, patients and health professionals, identification and sharing of best and promising practices and approaches and implementable research results;
b) support for the design of integrated and coherent health policy approaches to key mental health challenges for children, such as those posed by the digital world (e.g., misinformation, cyberbullying, body shaming, aggressive marketing, undue access to inappropriate content, addiction and concentration deficit);
c) support for the design of comprehensive and coherent policy approaches and toolkits to address key social, environmental, commercial and behavioural factors influencing the mental health of citizens, including children and young people and their mental resilience;
d) better and earlier detection and intervention of mental health problems through development, piloting and implementation of approaches and tools for early detection and intervention in various settings e.g., schools, workplaces, prisons and community settings;
e) improved access to evidence-based, innovative, promising and community-level approaches and interventions in the management of mental health challenges;
f) improved quality of life through appropriate and patient-centred follow-up care with a focus on rights and breaking through stigma and discrimination.
Budget: Topic budget: 2.000.000 EUR.
Expected nr of grant agreements to be signed: 4
Expected duration: 36 months
Indicative project budget: 500.000 EUR
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: At least one NGO working in the field of mental health; At least one patient organisation working in the field of mental health.
Other eligibility conditions: Academia and education establishments, research institutes, hospitals, expert networks including ERNs, civil society organisations: associations, foundations, NGOs and similar entities, established networks in the field of public health.
Scope: The activities could cover the following areas of action:
a) promotion of good mental health and prevention of mental health problems through mental health literacy and awareness-raising, knowledge-sharing and exchange programmes for health professionals, creation of and participation in networks of institutions, patients and health professionals, identification and sharing of best and promising practices and approaches and implementable research results;
b) support for the design of integrated and coherent health policy approaches to key mental health challenges for children, such as those posed by the digital world (e.g., misinformation, cyberbullying, body shaming, aggressive marketing, undue access to inappropriate content, addiction and concentration deficit);
c) support for the design of comprehensive and coherent policy approaches and toolkits to address key social, environmental, commercial and behavioural factors influencing the mental health of citizens, including children and young people and their mental resilience;
d) better and earlier detection and intervention of mental health problems through development, piloting and implementation of approaches and tools for early detection and intervention in various settings e.g., schools, workplaces, prisons and community settings;
e) improved access to evidence-based, innovative, promising and community-level approaches and interventions in the management of mental health challenges;
f) improved quality of life through appropriate and patient-centred follow-up care with a focus on rights and breaking through stigma and discrimination.
Budget: Topic budget: 2.000.000 EUR.
Expected nr of grant agreements to be signed: 4
Expected duration: 36 months
Indicative project budget: 500.000 EUR
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: At least one NGO working in the field of mental health; At least one patient organisation working in the field of mental health.
Other eligibility conditions: Academia and education establishments, research institutes, hospitals, expert networks including ERNs, civil society organisations: associations, foundations, NGOs and similar entities, established networks in the field of public health.
Call Identifier: EU4H-2024-PJ-03-2– a/b/c (DP/CR-g-24-29) Call for proposals on health promotion and prevention of noncommunicable and communicable diseases, including vaccine-preventable and other cancers caused by infections, and on smoke-and aerosol-free environments
Scope: The activities could cover the following areas of action:
a) promotion of good mental health and prevention of mental health problems through mental health literacy and awareness-raising, knowledge-sharing and exchange programmes for health professionals, creation of and participation in networks of institutions, patients and health professionals, identification and sharing of best and promising practices and approaches and implementable research results;
b) support for the design of integrated and coherent health policy approaches to key mental health challenges for children, such as those posed by the digital world (e.g., misinformation, cyberbullying, body shaming, aggressive marketing, undue access to inappropriate content, addiction and concentration deficit);
c) support for the design of comprehensive and coherent policy approaches and toolkits to address key social, environmental, commercial and behavioural factors influencing the mental health of citizens, including children and young people and their mental resilience;
d) better and earlier detection and intervention of mental health problems through development, piloting and implementation of approaches and tools for early detection and intervention in various settings e.g., schools, workplaces, prisons and community settings;
e) improved access to evidence-based, innovative, promising and community-level approaches and interventions in the management of mental health challenges;
f) improved quality of life through appropriate and patient-centred follow-up care with a focus on rights and breaking through stigma and discrimination.
Budget: Topic budget EU4H-2024-PJ-03-2 – a: 750.000 EUR; EU4H-2024-PJ-03-2 – b: 833.333 EUR; EU4H-2024-PJ-03-2 – c: 500.000 EUR.
Expected nr of grant agreements to be signed: EU4H-2024-PJ-03-2 – a: 2; EU4H-2024-PJ-03-2 – b: 3; EU4H-2024-PJ-03-2 – c: 2.
Expected duration: 36 months
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.
Call Identifier: EU4H-2024-PJ-03-3 (CR-g-24-42) Call for Proposals on radiation safety and quality of computed tomography imaging of children and young adults - (CR-g-24-42) EU4H-2024-PJ-03-3
Scope: The activities carried out in this action should include the following:
a) review of referral guidelines for imaging, clinical guidelines, and clinical decision support systems in use in Member States for justification of radiological imaging in children, adolescents and young adults and recommendations for improvement of these guidelines to the relevant actors;
b) review of the equipment base and the access to dedicated paediatric imaging in Member States and recommendations for improvement of the equipment base to the relevant actors;
c) development of guidance, protocols and tools for optimisation of paediatric CT exams, for the CT devices and the clinical indications that are the most used in Europe;
d) the organisation of information and dissemination campaigns concerning recommendations, guidance, protocols and tools for justification and optimisation of paediatric imaging among the concerned hospitals and medical centres in all Member States;
e) development of education and training curricula, material, and tools on radiation protection of paediatric patients, for the applicable professional groups;
f) the organisation of a training of radiologists, radiographers, medical physicists, and radiology nurses in practical approaches to radiation protection of paediatric patients;
g) the organisation of information campaigns about the benefits, risks and radiation safety of imaging in paediatric, adolescent and young adult patients, targeted at parents and young adults.
Budget: Topic budget: 3.000.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 48 months
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: Academia and education establishments, research institutes, hospitals, expert networks, civil society organisations, associations, foundations, NGOs, enterprises (incl. social enterprises and not for profit) in the field of public health, private entities (for profit/not for profit), international organisations, Member States’ authorities.
Call Identifier: EU4H-2024-PJ-03-4 (CR-g-24-99) Call for proposals on Personalised Cancer Medicine - (CR-g-24-99) EU4H-2024-PJ-03-4
Scope: Activities will contribute to the Joint Action on Personalized Cancer Medicine’, and include:
a) the implementation of targeted projects involving civil society organisations and industry complementing the Member States’ efforts in the design, planning and implementation of best practices (e.g., on metastatic cancer);
b) the production of public health guidelines concerning personalised cancer medicine, genomic testing/screening and metastatic cancer management;
c) patients and caregivers consultations, and other actions that can benefit citizens directly;
d) preparation and roll out of innovative practices;
e) support capacity building actions such as training and twinning, health communication or health literacy.
Budget: Topic budget: 3.000.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 36 and 48 months
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.
Call Identifier: EU4H-2024-PJ-03-5 (CR-g-24-96) Call for proposals to support the establishment of new networks of expertise on cancer and cancer conditions - (CR-g-24-96) EU4H-2024-PJ-03-5
Scope: Activities will complement the joint action on new networks of expertise to be launched under the EU4Health work programme 2023 (CR-g-23-40.1-2), and include:
a) implementing targeted projects involving patient organisations, civil societies, non-government organisations complementing the Member States’ efforts in the design, planning and implementation of the networks;
b) the establishment of best practices, the production of public health, treatment guidelines, or other actions that can benefit patients;
c) the preparation and roll out of innovative practices (pilot tests), and support actions such as training and twinning, health communication or health literacy.
Support activities could include:
a) practical support (to help patients better understand the impact of cancer and treatment; managing the side effects of cancer and cancer treatment);
b) emotional support (regular consultations in support groups and workshops, aimed at supporting and helping patients to manage the difficult psychological and emotional impact of cancer);
c) education and information (practical information on diet in cancer, oncology workshops for healthcare professionals and support personnel, tailored to specific types of cancer and their symptoms).
Budget: Topic budget: 1.000.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 36 months
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.
Call Identifier: EU4H-2024-PJ-03-6 (DI-g-24-76) Call for proposals on advancing the adoption of artificial intelligence in health (DI-g-24-76) EU4H-2024-PJ-03-6
Scope: The activities for this action should include the following actions:
a) the setting up and running of one or more communities of experts and relevant stakeholders for delving into the potentials and challenges concerning AI deployment in clinical practice. In this respect, this should provide proposals on how to ensure sustainability of this expert community beyond the end of the project;
b) the analysis and identification of the factors that lead to the successful and less successful deployment of AI in healthcare as well as challenges and obstacles, in collaboration with the expert community or communities mentioned under point a) and taking into account existing studies and projects. Two particular areas of interest that should be included are AI in cancer and AI in remote areas and medical deserts;
c) the preparation of good deployment practices for AI in healthcare, recommendations and guidelines tailored to the needs of the specific users/environments in healthcare to accelerate the safe and effective deployment of AI in clinical practice in collaboration with the expert community or communities mentioned under point a) and taking into account existing studies and projects.
d) the design, development, and execution of pilots to test and evaluate in diverse real-life environments the expert community(ies)’s developed good deployment practices, guidelines and recommendations. As part of the pilots, to analyse how clinical practice is changing with the incorporation of AI systems.
e) the development of user friendly interactive digital tool(s) that allows for the collection and communication of AI solutions successfully deployed in different clinical settings.
f) the organisation of workshops and communication activities addressed to different stakeholders.
g) the provision of a summary of lessons learned and recommendations for potential policy measures that would contribute to accelerating the safe and effective deployment of AI in clinical practice.
Budget: Topic budget: 4.500.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 36 and 48 months
Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.
Other Calls
National Calls
Italia domani - PNRR
Bandi e avvisi dei soggetti attuatori
Call Identifier: https://www.italiadomani.gov.it/content/sogei-ng/it/it/opportunita/bandi-soggetti-attuatori.html
Bandi e avvisi dei soggetti attuatori
In questa sezione è possibile consultare bandi e avvisi pubblici per cogliere le opportunità del PNRR volte a migliorare la vita pubblica di tutto il Paese.
Budget: Consultare il sito del bando
Deadline: Consultare il sito del bando
Who can apply: Consultare il sito del bando.
In questa sezione è possibile consultare bandi e avvisi pubblici per cogliere le opportunità del PNRR volte a migliorare la vita pubblica di tutto il Paese.
Budget: Consultare il sito del bando
Deadline: Consultare il sito del bando
Who can apply: Consultare il sito del bando.
Finanziamento IKIGAI - FMPS
Finanziamento di progetti individuali
Call Identifier: https://ikigai.fondazionemps.it/il-bando/
BANDO IKIGAI 2022 – 2024
Budget: Il bando sarà gestito con la collaborazione tecnica di Pluriversum Srl, società identificata dalla Fondazione come partner del progetto in virtù della consolidata conoscenza regionale di promozione e sostegno all’occupazione della società.
Per le modalità di erogazione e di partecipazione alle misure si rimanda agli specifici bandi e call che saranno pubblicati sui canali di comunicazione di IKIGAI (sul sito ikigaihub.it e sulle pagine social di IKIGAI), sui canali di comunicazione di Fondazione MPS (fondazionemps.it e ikigai.fondazionemps.it) e sulle comunicazioni a stampa.
Deadline: Consultare il sito del bando
Who can apply: Consultare il sito del bando.
Budget: Il bando sarà gestito con la collaborazione tecnica di Pluriversum Srl, società identificata dalla Fondazione come partner del progetto in virtù della consolidata conoscenza regionale di promozione e sostegno all’occupazione della società.
Per le modalità di erogazione e di partecipazione alle misure si rimanda agli specifici bandi e call che saranno pubblicati sui canali di comunicazione di IKIGAI (sul sito ikigaihub.it e sulle pagine social di IKIGAI), sui canali di comunicazione di Fondazione MPS (fondazionemps.it e ikigai.fondazionemps.it) e sulle comunicazioni a stampa.
Deadline: Consultare il sito del bando
Who can apply: Consultare il sito del bando.